The prenatal diagnosis of congenital disorders of glycosylation (CDG)

Prenatal Diagnosis

Volumn 24, Issue 2, 2004, Pages 114-116

  Matthijs, Gert ^a   Schollen, Els ^a   Van Schaftingen, Emile ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; GLYCOPROTEIN; OLIGOSACCHARIDE; PHOSPHOMANNOMUTASE;

AUTOSOMAL RECESSIVE DISORDER; CONGENITAL DISORDER OF GLYCOSYLATION; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 1A; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 1B; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 1C; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 2; GENE; GENE MUTATION; HUMAN; ISOELECTRIC FOCUSING; MPI GENE; NOTE; PMM2 GENE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

CARBOHYDRATE METABOLISM, INBORN ERRORS; GLUCOSYLTRANSFERASES; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; MANNOSE-6-PHOSPHATE ISOMERASE; MEMBRANE PROTEINS; MUTATION; PHOSPHOTRANSFERASES (PHOSPHOMUTASES); PRENATAL DIAGNOSIS;

EID: 1542291044     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.815     Document Type: Note

References (12)

1. Aebi M, Helenius A, Schenk B, et al. 1999. Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: an updated nomenclature for CDG. Glycoconj J 16: 669-671.
2. Aebi M, Hennet T. 2001. Congenital disorders of glycosylation: genetic model systems lead the way. Trends Cell Biol 11: 136-141.
3. Clayton P, Winchester B, Di Tomaso E, Young E, Keir G, Rodeck C. 1993. Carbohydrate-deficient glycoprotein syndrome: normal glycosylation in the fetus. Lancet 341: 956.
4. Hewitt JE, Grewal PK. 2003. Glycosylation defects in inherited muscle disease. Cell Mol Life Sci 60: 251-258.
5. Grünewald S, Schollen E, Van Schaftingen E, Jaeken J, Matthijs G. 2001. High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-1a (phosphomannomutase deficiency). Am J Hum Genet 68: 347-354.
6. Grünewald S, Matthijs G, Jaeken J. 2002. Congenital disorders of glycosylation: a review. Pediatr Res 52: 618-624.
7. Harms HK, Zimmer KP, Kumik K, Bertele-Harms RM, Weidinger S, Reiter K. 2002. Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency. Acta Paediatr 91: 1065-1072.
8. Jaeken J, Matthijs G, Carchon H, Van Schaftingen E. 2001. Defects of N-glycan synthesis. In The Metabolic and Molecular Bases of Inherited Diseases, Scriver CR, Beaudet AL, Sly SL, Valle D (eds). McGraw-Hill: New York; 1601-1622.
9. Jaeken J. 2003. Komrower lecture. Congenital disorders of glycosylation (CDG): it's all in it! J Inherit Metab Dis 26: 99-118.
10. Matthijs G, Schollen E, Bjursell C, et al. 2000. Mutations in PMM2 that cause congenital disorders of glycosylation, type 1a (CDG-1a). Hum Mutat 16: 386-394.
11. Matthijs G, Schollen E, Cassiman JJ, Cormier-Daire V, Jaeken J, van Schaftingen E. 1998. Prenatal diagnosis in CDG1 families: beware of heterogeneity. Eur J Hum Genet 6: 99-104.
12. Schollen E, Kjaergaard S, Legius E, Schwartz M, Matthijs G. 2000. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-1a (congenital disorders of glycosylation type 1a). Eur J Hum Genet 8: 367-371.